C$5.19
10.05%
Toronto, Oct 10, 10:00 pm CET
ISIN
CA94947L1022
Symbol
WELL

WELL Health Technologies Target price 2025 - Analyst rating & recommendation

WELL Health Technologies Classifications & Recommendation:

Buy
90%
Hold
10%

WELL Health Technologies Price Target

Target Price C$7.96
Price C$5.19
Potential
Number of Estimates 16
16 Analysts have issued a price target WELL Health Technologies 2026 . The average WELL Health Technologies target price is C$7.96. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 20 analysts: 18 Analysts recommend WELL Health Technologies to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the WELL Health Technologies stock has an average upside potential 2026 of . Most analysts recommend the WELL Health Technologies stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion C$ 0.92 1.45
18.51% 57.66%
EBITDA Margin 4.52% 13.84%
63.22% 206.42%
Net Margin 3.55% 3.98%
34,296.09% 12.25%

16 Analysts have issued a sales forecast WELL Health Technologies 2025 . The average WELL Health Technologies sales estimate is

C$1.5b
Unlock
. This is
32.32% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
C$1.5b 38.71%
Unlock
, the lowest is
C$1.4b 25.85%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 C$920m 18.51%
2025
C$1.5b 57.66%
Unlock
2026
C$1.6b 10.14%
Unlock
2027
C$1.7b 7.89%
Unlock
2028
C$1.8b 5.69%
Unlock

16 Analysts have issued an WELL Health Technologies EBITDA forecast 2025. The average WELL Health Technologies EBITDA estimate is

C$201m
Unlock
. This is
195.96% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
C$212m 212.74%
Unlock
, the lowest is
C$183m 170.22%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 C$41.5m 56.41%
2025
C$201m 383.20%
Unlock
2026
C$210m 4.60%
Unlock
2027
C$230m 9.42%
Unlock
2028
C$211m 8.24%
Unlock

EBITDA Margin

2024 4.52% 63.22%
2025
13.84% 206.42%
Unlock
2026
13.15% 4.99%
Unlock
2027
13.33% 1.37%
Unlock
2028
11.58% 13.13%
Unlock

15 WELL Health Technologies Analysts have issued a net profit forecast 2025. The average WELL Health Technologies net profit estimate is

C$57.7m
Unlock
. This is
144.86% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
C$120m 193.04%
Unlock
, the lowest is
C$-24.8m 80.70%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 C$32.6m 40,662.50%
2025
C$57.7m 76.94%
Unlock
2026
C$76.7m 32.98%
Unlock
2027
C$92.1m 20.08%
Unlock

Net Margin

2024 3.55% 34,296.09%
2025
3.98% 12.25%
Unlock
2026
4.80% 20.60%
Unlock
2027
5.35% 11.46%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share C$ 0.13 0.23
76.92%
P/E 22.78
EV/Sales 1.27

15 Analysts have issued a WELL Health Technologies forecast for earnings per share. The average WELL Health Technologies EPS is

C$0.23
Unlock
. This is
144.23% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
C$0.47 190.38%
Unlock
, the lowest is
C$-0.10 80.77%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 C$0.13
2025
C$0.23 76.92%
Unlock
2026
C$0.30 30.43%
Unlock
2027
C$0.36 20.00%
Unlock
2028
C$0.27 25.00%
Unlock

P/E ratio

Current -9.98 161.69%
2025
22.78 328.24%
Unlock
2026
17.13 24.80%
Unlock
2027
14.27 16.70%
Unlock

Based on analysts' sales estimates for 2025, the WELL Health Technologies stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.68 10.53%
2025
1.27 24.44%
Unlock
2026
1.15 9.21%
Unlock
2027
1.07 7.31%
Unlock
2028
1.01 5.37%
Unlock

P/S ratio

Current 1.20 2.15%
2025
0.91 24.43%
Unlock
2026
0.83 9.20%
Unlock
2027
0.76 7.32%
Unlock
2028
0.72 5.37%
Unlock

Current WELL Health Technologies Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
TD COWEN
Locked
Locked
Locked Sep 05 2025
SCOTIABANK GBM
Locked
Locked
Locked Sep 02 2025
STIFEL CANADA
Locked
Locked
Locked Aug 21 2025
CORMARK SECURITIES INC.
Locked
Locked
Locked Aug 18 2025
CIBC CAPITAL MARKETS
Locked
Locked
Locked Aug 18 2025
MAXIM GROUP
Locked
Locked
Locked Aug 15 2025
BEACON SECURITIES
Locked
Locked
Locked Aug 15 2025
Analyst Rating Date
Locked
TD COWEN:
Locked
Locked
Sep 05 2025
Locked
SCOTIABANK GBM:
Locked
Locked
Sep 02 2025
Locked
STIFEL CANADA:
Locked
Locked
Aug 21 2025
Locked
CORMARK SECURITIES INC.:
Locked
Locked
Aug 18 2025
Locked
CIBC CAPITAL MARKETS:
Locked
Locked
Aug 18 2025
Locked
MAXIM GROUP:
Locked
Locked
Aug 15 2025
Locked
BEACON SECURITIES:
Locked
Locked
Aug 15 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today